Abstract Submission
The FPHC 2025 organisers are pleased to invite abstracts for all conferencetracks from any and all interested parties.Authors should upload their abstracts via the web-based platform. Should youhave difficulties navigating the platform, please contact FPHCabstracts@babcock.edu.ng
Subthemes/Thematic tracks
Abstracts are invited for workshops and single presentations in all areas of public health research, practice, policy and education. Abstracts are considered for oral and poster presentations. Workshop proposals are considered for 60-minutes sessions. Abstracts are invited for the following
abstract submission topics:
Sub-Themes
1. Digital and Innovative health technologies of disrupting public health Service delivery: Role of AI, big data, Medtech and telemedicine in Public health service delivery.
2. Enhancing Public Health Service delivery through the Grand Convergence (GC) of financing the Health SDGs: Including, for domestic resource mobilization, impact of the principle of universality of SDGs, pooling and
allocation, strategic purchasing; results based financing, and financing strategies to reduce inequity and to increase financial risk protection in the informal sector.
3. Policy and Collaboration to advance One Health, Environmental & Occupational Health, neuro-epidemiology and Mental health
4. Epidemic Prevention, Health system strengthening a critical imperative for service delivery: Building resilient health systems capable of withstanding crisis, building health workforce for service delivery, HIV/AIDS.
5. Health equity Now: Ensuring equitable access to health services to promote maternal & child health, Reproductive health, Nutrition and
6 .Enhancing Partnerships as Public Health service delivery disruptive tools for social accountability: The role of Engaging Private Sector, NGOs, and the Academia in improving Public Health outcomes, learning from the community, and working in pursuance of a socially responsive engaged community.
Eligibility of Abstracts and Authors:
Only abstracts with original work within the above tracks will be accepted for the conference. The lead author must have participated in the activities showcased in the abstract and obtained the necessary approvals where
sensitive data is used in the paper, as well as any necessary ethical clearance documents.
While an author may submit more than one abstract, only one abstract per person (lead author) will be accepted. Research should have been conducted within the 2022-2025 period to ensure relevance to the Nigerian or African landscape. Abstracts that have been previously presented elsewhere will be considered at the Abstract Committee’s discretion, but priority will be given to abstracts that have not yet been presented at any other scientific conference. It is important that Authors should emphasize how the work undertaken was used to create a positive impact on the public health landscape and/or how the research will change the course of public health practice in the future.
Conflict of Interest: Authors of accepted abstracts will have to submit a disclosure of conflict-of-interest form that will be shared with the acceptance letter.
Abstract Scholarships: There may be a limited number of scholarships available to cover registration, travel and accommodation expenses for early career abstract presenters. Must be 40 years or younger, be a Masters/PhD
student or have obtained an MD, Masters or PhD in the last 5 years to be eligible. Should you wish to apply for a scholarship, you will be prompted during the submission process to check a box if you would like to be
considered for this support. To request this support, a statement of need is required to accompany your abstract. However, please note that indicating your interest in such support does not guarantee selection for a scholarship. No scholarships will be awarded to abstract applicants whose abstracts are not selected for oral or
poster presentations. Applicants will be notified if any scholarships are awarded along with the notification of the acceptance or rejection of their abstracts.
Word count: The abstract should not exceed 300 words (which includes subheadings but does not include the title, key words, list of authors and their addresses).
Authors: Authors should be listed as follows:
● First author: Provide first name, initials of the middle name (if any), and the last name (e.g., Henry M. Kuku).
● Co-authors: List each co-author in order of contribution by typing their first and middle names as initials, followed by their last name in full (e.g., J.N. Toto, C.H. Kwakweri).
● Provide the organizational affiliations of the first author and all co-authors.
● Indicate the corresponding author with an asterisk* and provide their email address and telephone number plus their alternate contacts.
Keywords: Please include 4– 6 keywords
Title: The title should be informative but concise with no subtitles or abbreviations/acronyms and should highlight what the study/subject is, where it was done and when it was undertaken (e.g., Cluster of COVID-19 cases in Keke district, August 2021). Write the title in sentence case and only capitalize proper nouns and scientific names where appropriate (e.g., Plasmodium falciparum).
OPTION 1: For scientific abstracts
Introduction/Background: Address the scientific background, rationale for the study, as well as the public health significance of the subject. Because of the anticipated diversity of the reviewers and those attending the conference, do not assume that everyone will be familiar with your topic. Explain why your study is important and what question(s) it will answer. A clearly stated background sets the stage and should include:
● A brief description of the topic and its public health significance
● Study objectives
● Research questions or study hypothesis if applicable Methods: Describe the methods used for the study. Essential points to be included are:
● Study design
● Study setting
● Study population
● Eligibility criteria and case definitions, if any
● Sample size and sampling methods
● Data management and analysis
Results: Present the significant findings (both positive and negative) of the study that are directly related to the study objectives. This section should not include discussion of the results. Provide absolute numbers and their
percentages/proportions, rates and ratios where applicable. Please note that since an abstract is a stand-alone and citable document, the results section should contain data.
It should not include such statements as “Data will be discussed.” If considerable work is still pending before the conference submission, please indicate that the results are preliminary.
Conclusion: Be as concise as possible. Do not re-state data included in the results. This section may include:
● An interpretation of key findings and their implications for public health practice
● Public health actions that are recommended and/or have been implemented as a consequence of the study
● Concluding statements such as results will be discussed are not acceptable
OPTION 2: For policy and programmatic abstracts If you have lessons learnt through programmes, projects or implementation of policies and strategies, you may submit an abstract following this alternate structure:
● Background: Summarize the purpose, scope of work and objectives of the programme, project, policy or strategy.
● Description: Describe the implementation period, setting and location, the structure, key population (if applicable) and activities and interventions undertaken.
● Lessons Learnt: Present in detail the findings and/or outcomes of the programme, project, policy, or strategy. Present an analysis or evaluation of key lessons learnt and best practices.
● Conclusions/next steps: Explain the significance of the findings and/or outcomes of the programme, project, or policy.
Note: Changes cannot be made to the final abstract after it has been submitted. However, in the event that your abstract is selected for presentation and has undergone significant changes after acceptance, those changes
should be highlighted in the abstract presentation or poster.
Evaluation Criteria
Each abstract will be evaluated by independent reviewers using the following
criteria:
● Background and rationale of the study
● Appropriateness of methods or description
● Presentation of results
● Conclusion and interpretation of results
● Public health significance
● Overall clarity of the abstract
● Novelty of the study
● Relevance to conference track/theme
Decisions and Next Steps
Publication in official 2024 Abstracts Book: All accepted abstracts will be published in the official FPHC 2025 Abstracts Book. Publication A select number of accepted abstract authors will also be provided support from the FPHC 2025 Team in writing their manuscripts for publication in
Babcock Medical Journal and in the Journal of Public and Allied Health.
Live presentations and poster hall: FPHC 2025 is an in-person meeting. All selected abstract applicants, whether selected for oral or poster presentations, are expected to be able to attend the conference in Babcock University, Ilishan-Remo Ogun State Nigeria. For more information about FPHC2025, visit www.fphc2025.babcock.edu.ng For questions about the abstracts program, please email
FPHCabstracts@babcock.edu.ng